Tiffany Eul Davis Inglis sold $16k of SERA
Chief Medical Officer at SERA PROGNOSTICS, INC.. 8,024 shares at an average of $2.03, traded Oct 12, 2026, filed Oct 13, 2026.
Score components
This filing reached EDGAR on Oct 13, 2026, so its score and components open to free visitors on Oct 20, 2026. The trade itself, the rows in the filing and the price context are public now.
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002091798-26-000010, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | SOpen-market sale Class A Common Stock | -8,024 | $2.03 | $16k | 83,565 | 13 h ago |
Related signals
Other insiders at SERA PROGNOSTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | SERA PROGNOSTICS, INC. | Dyaarl Lee Anderson Jr. Chief Commercial Officer | $3,600 1,800 shares | -2% | |
| 30Weak | SERA PROGNOSTICS, INC. | Tiffany Eul Davis Inglis Chief Medical Officer | $972 486 shares | -1% | |
| 30Weak | SERA PROGNOSTICS, INC. | Benjamin Jackson General Counsel | $4,380 2,190 shares | -1% | |
| 40Moderate | SERA PROGNOSTICS, INC. | Zhenya Lindgardt Chief Executive Officer | $14k 7,022 shares | -1% | |
| 46Moderate | SERA PROGNOSTICS, INC. | Zhenya Lindgardt Chief Executive Officer | $40k 20,139 shares | -2% | |
| 37Weak | SERA PROGNOSTICS, INC. | Austin Aerts Chief Financial Officer | $4,094 2,037 shares | -1% | |
| 30Weak | SERA PROGNOSTICS, INC. | Dyaarl Lee Anderson Jr. Chief Commercial Officer | $9,525 4,739 shares | -6% | |
| 30Weak | SERA PROGNOSTICS, INC. | Tiffany Eul Davis Inglis Chief Medical Officer | $728 362 shares | -0% | |
| 30Weak | SERA PROGNOSTICS, INC. | Benjamin Jackson General Counsel | $4,380 2,179 shares | -1% | |
| 40Moderate | SERA PROGNOSTICS, INC. | Zhenya Lindgardt Chief Executive Officer | $14k 6,990 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.